TLCR Reading Tools
How to cite item
Efficacy and safety of camrelizumab plus apatinib in previously treated patients with advanced non-small cell lung cancer harboring
EGFR
or
ALK
genetic aberration
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{65194}, author = {Gao, G., Ni, J., Wang, Y., Ren, S., Liu, Z., Chen, G., Gu, K., Zang, A., Zhao, J., Guo, R., He, J., Lin, X., Pan, Y., Ma, Z., Wang, Z., Fan, M., Liu, Y., Cang, S., Yang, X., Li, W., Wang, Q., Zhou, C.}, title = {Efficacy and safety of camrelizumab plus apatinib in previously treated patients with advanced non-small cell lung cancer harboring <em>EGFR</em> or <em>ALK</em> genetic aberration}, journal = {Translational Lung Cancer Research}, volume = {11}, number = {6}, year = {2022}, url = {https://tlcr.amegroups.org/article/view/65194} }